Subhas Gupta, MD
Plastic and Reconstructive Surgery · Loma Linda, CANPI 1659309805
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $124,363 of the $178,120 with a category attached, or 69.8%. Integra Lifesciences Corporation accounts for 91.1% of it on its own, with 32 other manufacturers making up the rest. 2025 is the largest year on record at $94,058, 9.8 times the $9,607 reported in 2019. Among plastic and reconstructive surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 280 payments — averaging $636.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$162K
- AbbVie$4K
- Johnson & Johnson$3K
- KCI USA, Inc.$3K
- Musculoskeletal Transplant Foundation Inc.$2K
- Solventum Corporation$1K
- plus $3K from 27 others
Across 6 payments — averaging $4490.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Avita Medical Americas, LLC$13K
- Innovation Technologies Inc$10K
- KCI USA, Inc.$4K
What the payments were for
- Consulting fees$124,36370%
- Speaking & faculty fees$10,3006%
- Travel & lodging$31,94618%
- Food & beverage$8,4335%
- Other$3,0782%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 161 | $162,347 |
| AbbVie(2 entities) | 13 | $3,759 |
| Johnson & Johnson | 1 | $3,078 |
| KCI USA, Inc. | 9 | $3,007 |
| Musculoskeletal Transplant Foundation Inc. | 10 | $1,554 |
| Solventum Corporation | 8 | $1,269 |
| Mentor Worldwide LLC | 15 | $446 |
| Innovation Technologies Inc | 4 | $418 |
| Vertex | 7 | $379 |
| Motiva USA, LLC | 8 | $328 |
| Axogen | 6 | $225 |
| Lifenet Health | 3 | $171 |
| Stryker(2 entities) | 3 | $150 |
| RTI Surgical, Inc | 2 | $146 |
| TELA Bio, Inc. | 4 | $135 |
| Sientra, Inc. | 2 | $121 |
| Acelrx Pharmaceuticals, Inc. | 2 | $85 |
| Checkpoint Surgical, Inc | 3 | $73 |
| Aroa Biosurgery Incorporated | 2 | $59 |
| Kls-martin L.p. | 1 | $53 |
| Mimedx Group, Inc. | 2 | $46 |
| Medline Industries LP | 1 | $45 |
| Smith+Nephew | 3 | $44 |
| Mesh Suture Inc | 1 | $31 |
| Novo Nordisk | 1 | $25 |
| Heron Therapeutics, Inc. | 1 | $23 |
| Bioventus LLC | 1 | $20 |
| Boston Scientific | 1 | $17 |
| Baxter Healthcare | 1 | $16 |
| Coopersurgical, Inc. | 1 | $16 |
| Zimmer Biomet | 1 | $15 |
| Medela LLC | 1 | $9 |
| Apyx Medical Corporation | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$244,963
- INTEGRA WOUND MATRIX (IWM)$26,988
- IDRT$17,374
- BILAYER WOUND MATRIX (BWM)$17,252
- FLOWABLE$17,252
- ADVANCED WOUND CARE$10,127
- INTEGRA MESHED BILAYER WOUND MATRIX$9,735
- PRIMATRIX$7,669
- INTEGRA DERMAL REGENERATION TEMPLATE$6,374
- PREVENA$2,822
- VAC VERAFLO$1,500
- KERRACONTACT AG (US)$1,500
- SNAP$1,500
- CODMAN CERTAS$1,350
- SURGIMEND$1,350
- ACTIVAC$1,200
- GENTRIX$1,016
- V.A.C. VERAFLO$953
- TENOGLIDE$941
- NEURAGEN NERVE GUIDE$825
How this compares
$178,120 in reported general payments places this provider in the 95th percentile of 349 plastic and reconstructive surgery providers in California.
See all plastic and reconstructive surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in Loma Linda
- Mark SuskiThousand Oaks$294K
- Corey MaasSan Francisco$286K
- Arian MowlaviLaguna Beach$250K
- Charles LeeSan Francisco$200K
- David SieberSan Francisco$195K
- David KulberLos Angeles$194K
- Matthew NykielUpland$181K
- Jeffrey HammoudehLos Angeles$159K
- Geoffrey GurtnerPalo Alto$127K
- Gregory BunckeSan Francisco$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.